Pfizer’s Albert Bourla and Hiroshi Matsumori on Established Brands In Japan: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Last week’s exclusive partnership with Mylan has put Pfizer in a much stronger position in Japan’s generics market. The question remains whether it can navigate Japan’s unique Gx challenges.